Global Virology V: 21st Century Vaccines and Viruses / edited by Paul Shapshak, Seetharaman Balaji, Pandjassarame Kangueane, Jens H. Kuhn, Charurut Somboonwit, John T. Sinnott

Mitwirkende(r):

Resource type: Ressourcentyp: Buch (Online)Buch (Online)Sprache: Englisch Verlag: Cham : Springer Nature Switzerland, 2025Verlag: Cham : Imprint: Springer, 2025Auflage: 1st ed. 2025Beschreibung: 1 Online-Ressource(XIII, 857 p. 71 illus., 59 illus. in color.)ISBN:

9783031779114

Schlagwörter:

579.2 23
616.96 23

DOI: DOI: 10.1007/978-3-031-77911-4Online-Ressourcen:

Zugang im Netz des KIT

Zusammenfassung: 1-15. Individual virus vaccines (Nipah, Hendra/Nipah/Henipaviridae peptides, Circovirus, Hantavirus, Prion, Influenza, Zika, Venezuelan EEV, HIV, etc.) -- 16. Cut-across vaccines -- 17. Strategies in vaccine development and testing -- 18. Prior and anticipated barriers to vaccines -- 19. Sociological and psychiatric barriers to vaccines -- 20. International issues and barriers in vaccine development and promulgation -- 21. Clinical applications of vaccine development, promulgation, and testing -- 22. Applications of CRISPR -- 23. Applications of siRNA -- 24. Nano-molecular vaccine adjuvant technology -- 25. Vaccine development in education -- 26. The intersection of animal, avian, and insect worlds -- 27. Honeybee discrimination -- 28. Jumping genes in maize -- 29. Exclusion of gene expression.Zusammenfassung: The purpose of this fifth volume in the Global Virology series is to describe and propose vaccines, focusing primarily on viral vaccines. In addition to human vaccines, animal viral vaccines are included since animals are used in vaccine research, and the spread of diseases to, from, and among animals, birds, and humans permeates the ecosystem. Due to climatic, geographical, and social factors, there is increased global spread of viruses and other infectious agents. Contributory factors include global warming, spread of vectors, increased human travel, encroachment into animal and avian environments, war, pestilence, malnutrition, and environmental, economic, and social collapse. GVV will address vaccines for many of the viruses addressed in previous series volumes, as well as for viruses not previously covered, and novel and future vaccine technologies. Advances in vaccine effectiveness and molecular engineering approaches are included, such as gene therapy, and CRISPR technologies.PPN: PPN: 193051025XPackage identifier: Produktsigel: ZDB-2-SEB | ZDB-2-SBL | ZDB-2-SXB

Exemplare ( 0 )
Titelinformationen ( 1 )

Dieser Titel hat keine Exemplare

Barrierefreier Inhalt: Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub.